Top compounds associated with response to LIMD2


Feature Type Standardized
Nominal ANOVA
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.31 3e-10
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.27 4e-09
mRNA SN-38 CTRPv2 pan-cancer AAC 0.29 8e-09
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.25 3e-08
mRNA YM-155 CTRPv2 pan-cancer AAC 0.29 3e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.22 5e-08
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.26 5e-08
mRNA etoposide CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 3e-07
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.21 6e-07
Download CSV